Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Rang in Aktien #7110
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Aktienkurs
$99.16
Zuletzt synchronisiert: 2026-08-27
Marktkapitalisierung
$1.72B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
2.52%
Land
ES
Handel Pharma Mar, S.A. (PHM)

Kategorie

Kursverlauf für Pharma Mar, S.A. (PHM)
Höchster Schlusskurs: $97.96 am 2026-08-01

Niedrigster Schlusskurs: $218.83 am 2000-09-01
Kursverlauf der Aktie von Pharma Mar, S.A. von 2000 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 11.19%
2025 7.04%
2024 82.98%
2023 -37.27%
2022 15.74%
2021 -33.18%
2020 155.86%
2019 122.05%
2018 -52.82%
2017 5.76%
2016 -18.80%
2015 -2.25%
2014 5.71%
2013 96.55%
2012 -18.58%
2011 -45.75%
2010 -36.04%
2009 20.26%
2008 -51.99%
2007 35.46%
2006 3.21%
2005 0.67%
2004 7.60%
2003 2.35%
2002 -18.68%
2001 -49.94%
2000 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$765.25 7.74%
CH